Recombinant Human SUMO3 Protein, CF

Images

 
There are currently no images for SUMO3 (UL-762).

Every product we sell is backed by Novus' 100% Guarantee. If you have used this product, please submit your images and reviews to earn reward points.

Product Details

Summary
Reactivity HuSpecies Glossary
Applications Enzyme Activity
Format
Carrier-Free

Order Details

Recombinant Human SUMO3 Protein, CF Summary

Details of Functionality
Recombinant Human SUMO3 can be conjugated to substrate proteins via the subsequent actions of an SUMO-activating (E1) enzyme, an SUMO-conjugating (E2) enzyme, and an SUMO ligase (E3). Reaction conditions will need to be optimized for each specific application. We recommend an initial Recombinant Human SUMO3 concentration of 10-50 μM.
Source
E. coli-derived human SUMO3 protein
Accession #
Protein/Peptide Type
Recombinant Proteins
Gene
SUMO3
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain

Applications/Dilutions

Theoretical MW
11 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Publications
Read Publication using
UL-762 in the following applications:

Packaging, Storage & Formulations

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -70 °C as supplied.
  • 3 months, -70 °C under sterile conditions after opening.
Buffer
X mg/ml (X μM) in 50 mM HEPES pH 8.0, 150 mM NaCl, 1 mM DTT
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human SUMO3 Protein, CF

  • SMT3 (suppressor of mif two 3, yeast) homolog 1
  • SMT3 homolog 1
  • SMT3 suppressor of mif two 3 homolog 1
  • SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae)
  • SMT3 suppressor of mif two 3 homolog 3 (yeast)
  • SMT3A
  • SMT3B
  • SMT3H1
  • SMT3H1small ubiquitin-related modifier 3
  • SUMO-2
  • SUMO3
  • SUMO-3
  • ubiquitin-like protein SMT3A
  • Ubiquitin-like protein SMT3B

Background

Human Small Ubiquitin-like Modifier 3 (SUMO3), also known as SMT3A, is synthesized as a 103 amino acid (aa), propeptide with a predicted 11.5 kDa. SUMO3 contains a two aa C-terminal prosegment. Human SUMO3 shares 83% sequence identity with mouse SUMO3. SUMO3 also has high aa sequence homology to SUMO2 and SUMO4, 87% and 75%, respectively. SUMO3 shares only 47% sequence identity with SUMO1. SUMOs are a family of small, related proteins that can be enzymatically attached to a target protein by a post-translational modification process termed SUMOylation (1-3). All SUMO proteins share a conserved Ubiquitin domain and a C-terminal diglycine cleavage/attachment site. Following prosegment cleavage, the C-terminal glycine residue of SUMO3 is enzymatically attached to a lysine residue on a target protein. In humans, SUMO3 is conjugated to a variety of molecules in the presence of the SAE1/UBA2 SUMO-activating (E1) enzyme and the UBE2I/Ubc9 SUMO-conjugating (E2) enzyme (4,5). In yeast, the SUMO-activating (E1) enzyme is Aos1/Uba2p (6). Because of the high level of sequence homology most studies report effects of SUMO2/3. For example, addition of SUMO2/3 was shown to modulate the function of ARHGAP21, a RhoGAP protein known to be involved in cell migration (7). Other reports indicate that the conjugation by SUMO2/3, but not SUMO1, may represent an important mechanism to protect neurons during episodes of cerebral ischemia (8,9). However, studies suggest that SUMO2/3 expression is regulated in an isoform-specific manner since oxidative stress downregulated the transcription of SUMO3 but not SUMO2 (10).

The ubiquitin-like SUMO-3 is conjugated to a variety of proteins in the presence of UbcH9 and the SAE1/SAE2 (human) or Aos1/Uba2 (yeast) activating enzyme. SUMO-3 is derived from the precursor pro-SUMO-3 (Accession # NM_006936). Human SUMO-3 shares 47% and 87% identity with SUMO-1 and SUMO-2 respectively. SUMOylation can occur without the requirement of a specific E3 ligase activity, where SUMO is transferred directly from UbcH9 to specific substrates. SUMOylated substrates are primarily localized to the nucleus (RanGAP-1,RANBP2, PML, p53, Sp100, HIPK2) but there are also cytosolic substrates (I kappa B alpha, GLUT1,GLUT4). SUMO modification has been implicated in functions such as nuclear transport, chromosome segregation, transcriptional regulation, apoptosis, and protein stability.

  1. Desterro, J.M. et al. (1997) FEBs. Lett. 417:297.
  2. Bettermann, K. et al. (2012) Cancer Lett. 316:113.
  3. Praefcke, G.J. et al. (2012) Trends Biochem. Sci. 37:23.
  4. Okuma, T. et al. (1999) Biochem. Biophys. Res. Commun. 254:693.
  5. Tatham, M.H. et al. (2001) J. Biol. Chem. 276:35368.
  6. Johnson, E.S. et al. (1997) EMBO J. 16:5509.
  7. Bigarella, C.L. et al. (2012) FEBS Lett. 586:3522.
  8. Datwyler, A.L. et al. (2012) J. Cereb. Blood Flow Metab. 31:2152.
  9. Wang, Z. et al. (2012) Protein Expr. Purif. 82:174.
  10. Sang, J. et al. (2012) Biochem. J. 435:489.

Customers Who Viewed This Item Also Viewed...

NBP2-44477
Species: Hu, Rt
Applications: Flow, IHC, IHC-P, IF
NBP2-32901
Species: Hu, Rt
Applications: WB, Flow, ICC/IF, IHC, IHC-Fr, IHC-P
NB300-812
Species: Hu, Rt
Applications: WB, IHC, IHC-P, PEP-ELISA
NBP2-02623
Species: Hu, Rt, Ca
Applications: WB, Flow, ICC/IF, IHC, IHC-P
NB100-56406
Species: Hu, Mu
Applications: WB, IHC, IHC-P
NB100-56405
Species: Hu, Mu
Applications: WB, Simple Western, ICC/IF, IHC, IHC-P
NB100-93337
Species: Hu, Mu
Applications: WB, IP
NB100-59787
Species: Hu, Mu
Applications: WB, Flow, IB, ICC/IF, IHC, IHC-P, IP, PLA, KD
NBP1-56590
Species: Hu, Rt
Applications: WB, IHC, IF
NB600-1318
Species: Hu, Mu, Rt
Applications: WB, ICC/IF
NB200-103
Species: Hu, Mu, Rt, Ye, Xp(-)
Applications: WB, ELISA, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, CyTOF-ready, Flow-IC
NBP2-37523
Species: Hu
Applications: WB, ELISA, Flow, ICC/IF, IHC, IHC-P, CyTOF-ready
NBP1-89522
Species: Hu, Mu, Rt
Applications: WB, ICC/IF, IHC, IHC-P
H00026054-M01
Species: Hu
Applications: WB, ELISA, Flow, IHC, IHC-P
NBP1-89150
Species: Hu, Mu, Rt
Applications: WB, IHC, IHC-P
AF2574
Species: Hu
Applications: CyTOF-ready, ICFlow
NBP1-31302
Species: Hu, Mu, Rt
Applications: WB, ICC/IF, IHC, IHC-P
NB100-56603
Species: Hu, Mu, Pm
Applications: WB, IHC, IHC-P
NB120-22104
Species: Hu, Mu, Rt
Applications: WB
UL-762
Species: Hu
Applications: Enzyme Activity

Publications for SUMO3 (UL-762)(1)

We have publications tested in 1 confirmed species: Human.

We have publications tested in 1 application: Enzyme Assay.


Filter By Application
Enzyme Assay
(1)
All Applications
Filter By Species
Human
(1)
All Species
Showing Publication 1 - 1 of 1.
Publication using UL-762 Applications Species
SY Sohn, P Hearing Mechanism of Adenovirus E4-ORF3-Mediated SUMO Modifications MBio, 2019;10(1):. 2019 [PMID: 30808699] (Enzyme Assay, Human) Enzyme Assay Human

Reviews for SUMO3 (UL-762) (0)

There are no reviews for SUMO3 (UL-762). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for SUMO3 (UL-762) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.
Recombinant Monoclonal Antibodies

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our Recombinant Human SUMO3 Protein, CF and receive a gift card or discount.

Bioinformatics

Gene Symbol SUMO3
Uniprot
COVID-19 update